Release Date: 07/02/11 08:58 Summary: Form 484 - Cancellation of shares following buy-back Price Sensitive: No Download Document 469.29KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
